Oralics is an AI-powered saliva sensor that profiles the oral microbiome chairside — replacing weeks of sequencing with a single drop and a deep learning model trained on 16S rRNA ground truth.
The problem
Today's gold standard — 16S rRNA sequencing — takes weeks, costs hundreds of dollars per sample, and requires DNA extraction, PCR, and bioinformatics pipelines accessible only to centralized facilities.
That delay makes longitudinal research, point-of-care diagnostics, and population-scale screening impractical. Clinicians and patients are flying blind on a system that governs immunity, metabolism, and inflammation.
How it works
A single saliva sample — no swabs, no shipping, no cold chain.
Label-free microscopy and mass spectrometry capture a microbial fingerprint on-device.
Our deep learning model — trained against 16S rRNA sequencing — predicts dominant bacterial taxa in real time.
Insights stream to the companion app, linking microbial balance to symptoms, diet, and habits.
Where it matters
The oral cavity hosts ~26% of the body's bacteria and serves as the gateway to the GI and respiratory tracts. Imbalance here echoes everywhere.
Detect microbial shifts tied to insulin resistance and inflammation.
Monitor dysbiosis before it becomes disease.
>50% of the gut microbiome overlaps with the oral cavity — start upstream.
Track emerging links between oral dysbiosis and systemic risk.
Surface microbial risk factors during prenatal care.
A 'smart mirror' for how diet, sleep, and stress shape the mouth.
For investors
Oralics is building the infrastructure for the next decade of oral diagnostics.
Just as Fitbit transformed activity into continuous behavioral data, and CGMs transformed glucose into a real-time metabolic signal, Oralics is turning the oral microbiome into a longitudinal health intelligence platform.
The mouth is one of the body's richest biological interfaces — continuously reflecting changes across inflammation, metabolism, immunity, nutrition, and disease progression. Yet today, microbiome analysis remains expensive, episodic, and inaccessible to most consumers and providers.
Oralics changes that.
Using a simple saliva sample, AI-powered analysis, and longitudinal monitoring, Oralics delivers rapid, scalable insight into oral and systemic health — without the cost and latency of traditional sequencing.
Market opportunity
Conservative · highly defensibleMarket opportunity dashboard
TAM by category
TAM composition
Bars use a log scale so core microbiome categories stay legible alongside macro digital-health TAMs. Source projections from analyst reports across 2030–2035.
The platform
Oralics is not just building a diagnostic product. It is building a proprietary real-world biological dataset capable of powering:
The compounding loop
More users → more biological signal → better models → stronger clinical utility → more users.
Over time, Oralics has the potential to become the system of record for oral health intelligence.
Why now
Platform advantages
Actionable insights in minutes, not weeks.
Simple saliva-based workflow designed for broad adoption.
No dependence on high-cost sequencing infrastructure.
A proprietary longitudinal dataset that improves over time.
Integrated hardware + AI + data network effects.
Roadmap
Each phase compounds the last: data feeds models, models unlock indications, indications unlock clinical and payer partnerships.
Founding team
Co-founder · Oral epidemiology & microbiome research
Co-founder · Public health dentistry & translational science
Proof of concept underway at LabCentral, Cambridge MA · Reference sequencing via Rutgers University Microbiome Facility
We're talking to clinical partners, research collaborators, and mission-aligned investors. If that's you, we'd love to hear from you.